The Drug Regulatory Authority of Pakistan (Drap) has approved the N-CovKit diagnostic kits that have been developed by scientists at the National University of Science and Technology (Nust) after its trial was successfully completed.

Nust successfully performed lab trials of N-CovKit on 330 blinded samples. These indigenously established assays are robust, sensitive to the target and would soon be available in the market at a lower price compared to imported ones.

Federal Minister for Science and Technology Chaudhry Fawad Hussain also confirmed the news and extended his felicitations to both the leadership of Nust and the scientists.

Read the full story here.

Opinion

Editorial

A new deal
Updated 16 Jun, 2026

A new deal

AFTER three and a half months of war between US-Israel and Iran and an acrimonious temporary ceasefire, a genuine...
Charter of economy
16 Jun, 2026

Charter of economy

NO one expected the PTI to accept the government’s invitation to sign a charter of economy; just as few expected...
Hostage seamen
16 Jun, 2026

Hostage seamen

SOME 50 days on, 11 Pakistani nationals are still in Somali pirates’ captivity. Their appeals to the Pakistani and...
Climate choices
Updated 15 Jun, 2026

Climate choices

The country is confronting increasingly volatile weather patterns with consequences for agriculture, infrastructure, public health and economic planning.
Brief opening
15 Jun, 2026

Brief opening

WE have been here before. Throughout the weekend, there was great anticipation that a tentative framework for peace...
Environmental disaster
15 Jun, 2026

Environmental disaster

IT was a heartbreaking sight. A recent news report in these pages carried a picture of a sea turtle lying half ...